CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net Loss	$ (1,311,247)	$ (464,415)
Adjustments to reconcile net loss to net cash used in by operating activities -
Depreciation and amortization	48,290	51,564
Stock-based compensation expense	149,364	108,746
Non-cash interest expense	4,376	4,376
Changes in operating assets and liabilities -
Accounts receivable, net	421,896	(625,719)
Inventories, net	(592,521)	(194,995)
Prepaid expenses	10,889	(112,120)
Accounts payable	746,038	(698,603)
Contract liabilities	(65,804)	250,293
Accrued compensation and other	270,097	307,884
Net cash used in operating activities	(318,622)	(1,372,989)
Cash Flows from Investing Activities:
Purchases of fixed assets	(24,349)	(30,770)
Additional patent costs	(3,750)	(12,747)
Net cash used in investing activities	(28,099)	(43,517)
Cash Flows from Financing Activities:
Payments of capital lease obligations	(11,212)	(10,562)
Payments of long-term debt	(128,315)	(128,315)
Payment of debt modification costs	(15,000)	0
Payment on revolving line of credit	(500,000)	0
Proceeds from registered direct sale of common stock, net	1,204,542	0
Gross proceeds from the exercise of stock options	27,000	0
Net cash provided by (used in) financing activities	577,015	(138,876)
Net increase(decrease) in cash and cash equivalents	230,294	(1,555,383)
Cash and cash equivalents, beginning of period	405,278	2,925,852
Cash and cash equivalents, end of period	$ 635,572	$ 1,370,469